Blog Examines Respiratory Syncytial Virus Vaccine R&D

Bill & Melinda Gates Foundation’s “Impatient Optimists”: New Hope for Respiratory Syncytial Virus (RSV) Prevention
Niteen Wairagkar, senior program officer with the global health program’s pneumonia team at the Bill & Melinda Gates Foundation, discusses the need for and research into vaccines for respiratory syncytial virus (RSV), a leading cause of pneumonia in children, including one vaccine using a maternal immunization approach currently being tested in a phase 3 trial (12/10).